MTMR15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.88840004428693E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.24390000522112E-08 |
Normal-vs-Stage2 |
1.940270E-03 |
Normal-vs-Stage3 |
4.82419999947581E-07 |
Normal-vs-Stage4 |
1.828920E-04 |
Stage1-vs-Stage2 |
5.553600E-01 |
Stage1-vs-Stage3 |
6.867600E-02 |
Stage1-vs-Stage4 |
2.765800E-01 |
Stage2-vs-Stage3 |
1.120820E-01 |
Stage2-vs-Stage4 |
2.368400E-01 |
Stage3-vs-Stage4 |
9.115800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.67409999593826E-08 |
Normal-vs-AfricanAmerican |
2.57189999997021E-06 |
Normal-vs-Asian |
3.161100E-03 |
Caucasian-vs-AfricanAmerican |
9.892800E-01 |
Caucasian-vs-Asian |
4.558000E-01 |
AfricanAmerican-vs-Asian |
4.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.9959000008285E-08 |
Normal-vs-Female |
7.54160000004944E-07 |
Male-vs-Female |
8.002000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.81919999997504E-06 |
Normal-vs-Extreme_Weight |
3.18789999953495E-08 |
Normal-vs-Obese |
1.58345999999865E-05 |
Normal-vs-Extreme_Obese |
5.644600E-03 |
Normal_Weight-vs-Extreme_Weight |
7.231600E-01 |
Normal_Weight-vs-Obese |
6.996400E-01 |
Normal_Weight-vs-Extreme_Obese |
5.868400E-01 |
Extreme_Weight-vs-Obese |
4.078200E-01 |
Extreme_Weight-vs-Extreme_Obese |
4.548400E-01 |
Obese-vs-Extreme_Obese |
7.874400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.362200E-04 |
Normal-vs-Age(41-60Yrs) |
1.79900999999205E-05 |
Normal-vs-Age(61-80Yrs) |
7.20339998760977E-09 |
Normal-vs-Age(81-100Yrs) |
1.61279999999486E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.482800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.959600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.420200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.557150E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.588400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.295600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
7.39950000050449E-07 |
Normal-VS-Type2 PRCC |
1.73180003670836E-09 |
Normal-VS-KIRP CIMP |
2.00219999999529E-05 |
Normal-VS-Unclassified PRCC |
3.355600E-03 |
Type1 PRCC-VS-Type2 PRCC |
1.55429999981749E-07 |
Type1 PRCC-VS-KIRP CIMP |
7.779000E-03 |
Type1 PRCC-VS-Unclassified PRCC |
9.145600E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.222600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.141900E-02 |
KIRP CIMP-VS-Unclassified PRCC |
6.120000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.2376000031783E-08 |
Normal-vs-N1 |
2.36540000031482E-07 |
Normal-vs-N2 |
2.663500E-03 |
N0-vs-N1 |
3.588800E-01 |
N0-vs-N2 |
2.364800E-01 |
N1-vs-N2 |
5.383200E-01 |
|
|